Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)-Reference-Cited by-同舟云学术

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Published:2019-03 Issue:3 Volume:73 Page:309-315
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Mc Causland Finnian R.,Claggett Brian,Burdmann Emmanuel A.,Chertow Glenn M.,Cooper Mark E.,Eckardt Kai-Uwe,Ivanovich Peter,Levey Andrew S.,Lewis Eldrin F.,McGill Janet B.,McMurray John J.V.,Parfrey Patrick,Parving Hans-Henrik,Remuzzi Giuseppe,Singh Ajay K.,Solomon Scott D.,Toto Robert D.,Pfeffer Marc A.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Nephrology

Reference28 articles.

1. US Renal Data System 2016 Annual Data Report: epidemiology of kidney disease in the United States;Saran;Am J Kidney Dis,2017

2. Worldwide, mortality risk is high soon after initiation of hemodialysis;Robinson;Kidney Int,2014

3. High cardiovascular event rates occur within the first weeks of starting hemodialysis;Eckardt;Kidney Int,2015

4. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: the Kidney Early Evaluation Program;El-Achkar;Kidney Int,2005

5. Unrecognized anemia in patients with diabetes: a cross-sectional survey;Thomas;Diabetes Care,2003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics;Frontiers in Pharmacology;2024-06-19

2. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-02-13

3. Management of CKD;Nephrology Self-Assessment Program;2022-06

4. Epidemiology and outcomes in patients with anemia of CKD not on dialysis from a large US healthcare system database: a retrospective observational study;BMC Nephrology;2022-04-30

5. Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms;Cardiovascular Drugs and Therapy;2022-02-12